| Bioactivity | BIBR 1087 SE is an intermediate metabolite of dabigatran etexilate. | ||||||||||||
| Name | BIBR 1087 SE | ||||||||||||
| CAS | 212321-78-3 | ||||||||||||
| Formula | C32H37N7O5 | ||||||||||||
| Molar Mass | 599.68 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Stangier J, et al. Pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor, are not affected by moderate hepatic impairment. J Clin Pharmacol. 2008 Dec;48(12):1411-9. |